Validation of a population-based method to assess drug-induced alterations in the QT interval: a self-controlled crossover study

Population Pharmacokinetic and Concentration-QTc Models for Moxifloxacin: Pooled Analysis of 20 Thorough QT Studies

(2011) Jeffry A. Florian et al.   JOURNAL OF CLINICAL PHARMACOLOGY

QT Prolongation and Ventricular Fibrillation in Acute Myocardial Infarction

(2010) Gunilla Forssell et al.   ACTA MEDICA SCANDINAVICA

QT Interval in Relation to Ventricular Arrhythmias and Sudden Cardiac Death in Postmyocardial Infarction Patients

(2010) Mogens Møller   ACTA MEDICA SCANDINAVICA

Effects of high-dose ziprasidone and haloperidol on the QTc interval after intramuscular administration: A randomized, single-blind, parallel-group study in patients with schizophrenia or schizoaffective disorder

(2010) Jeffrey J. Miceli et al.   CLINICAL THERAPEUTICS

Cardiovascular Effects of Methylphenidate, Amphetamines and Atomoxetine in the Treatment of Attention-Deficit Hyperactivity Disorder

(2010) Gary Stiefel et al.   DRUG SAFETY

QT interval prolongation: prevalence, risk factors and pharmacovigilance data among methadone-treated patients in France

(2010) Aurélie Perrin-Terrin et al.   FUNDAMENTAL & CLINICAL PHARMACOLOGY

Genome-wide association study of antipsychotic-induced QTc interval prolongation

(2010) K Åberg et al.   PHARMACOGENOMICS JOURNAL

Prevalence and clinical relevance of corrected QT interval prolongation during methadone and buprenorphine treatment: a mortality assessment study

(2009) Katinka Anchersen et al.   ADDICTION

Structural determinants for histamine H1 affinity, hERG affinity and QTc prolongation in a series of terfenadine analogs

(2009) Robert Aslanian et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

AHA/ACCF/HRS Recommendations for the Standardization and Interpretation of the Electrocardiogram

(2009) Pentti M. Rautaharju et al.   CIRCULATION

New Prescription Medication Gaps: A Comprehensive Measure of Adherence to New Prescriptions

(2009) Andrew J. Karter et al.   HEALTH SERVICES RESEARCH

Psychotropic Drugs Associated With Corrected QT Interval Prolongation

(2009) Charlotte van Noord et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Association of antipsychotic and antidepressant drugs with Q-T interval prolongation

(2008) W. R. Zemrak et al.   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

Prolonged QT Interval, Syncope, and Delirium with Galantamine

(2008) Alexander A Fisher et al.   ANNALS OF PHARMACOTHERAPY

Valvular regurgitation and surgery associated with fenfluramine use: an analysis of 5743 individuals

(2008) Charles F Dahl et al.   BMC Medicine

Pharmacoepidemiology of QT-interval prolonging drug administration in critically ill patients

(2008) Bradley D. Freeman et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Drug induced shortening of the QT/QTc interval: An emerging safety issue warranting further modelling and evaluation in drug research and development?

(2008) Mark Holbrook et al.   JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS

Pulmonary arterial hypertension associated with fenfluramine exposure: report of 109 cases

(2007) R. Souza et al.   EUROPEAN RESPIRATORY JOURNAL